Literature DB >> 22157632

Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance?

Susanne Binder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22157632     DOI: 10.1136/bjophthalmol-2011-301236

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  65 in total

1.  Tachyphylaxis during ranibizumab treatment of exudative age-related macular degeneration.

Authors:  Sibel Doguizi; Sengul Ozdek; Selcen Yuksel
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

2.  Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration.

Authors:  Florian M Heussen; Qing Shao; Yanling Ouyang; Antonia M Joussen; Bert Müller
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-12-24       Impact factor: 3.117

3.  Induction of vascular endothelial growth factor receptor expression in human umbilical vein endothelial cells after repeated bevacizumab treatment in vitro.

Authors:  Ji Eun Lee; Jin Young Kim; Jae Ho Jung; Dong Hoon Shin; Sung Who Park
Journal:  Int J Ophthalmol       Date:  2017-07-18       Impact factor: 1.779

4.  Short-term results of switchback from aflibercept to ranibizumab in neovascular age-related macular degeneration in clinical practice.

Authors:  Raphaelle Despreaux; Salomon Y Cohen; Oudy Semoun; Olivia Zambrowski; Camille Jung; Hassiba Oubraham; Eric H Souied
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-06-20       Impact factor: 3.117

5.  Secretion of Down Syndrome Critical Region 1 Isoform 4 in Ischemic Retinal Ganglion Cells Displays Anti-Angiogenic Properties Via NFATc1-Dependent Pathway.

Authors:  Yue Xu; Boyu Yang; Yaguang Hu; Lin Lu; Xi Lu; Jiawei Wang; Qinmeng Shu; Qiaochu Cheng; Shanshan Yu; Fan Xu; Jingjing Huang; Xiaoling Liang
Journal:  Mol Neurobiol       Date:  2016-10-12       Impact factor: 5.590

6.  Retention of good visual acuity in eyes with neovascular age-related macular degeneration and chronic refractory subfoveal subretinal fluid.

Authors:  Kavita V Bhavsar; K Bailey Freund
Journal:  Saudi J Ophthalmol       Date:  2014-03-12

7.  The ocular toxicity and pharmacokinetics of simvastatin following intravitreal injection in mice.

Authors:  Dennis Y Tse; Seong Jae Kim; Inyoung Chung; Feng He; Theodore G Wensel; Samuel M Wu
Journal:  Int J Ophthalmol       Date:  2017-09-18       Impact factor: 1.779

8.  Therapeutic potential of intravitreal pharmacotherapy in retinal vein occlusion.

Authors:  Marianne L Shahsuvaryan
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

9.  Evaluating Efficacy of Aflibercept in Refractory Exudative Age-Related Macular Degeneration With OCT Segmentation Volumetric Analysis.

Authors:  Catherine S Choi; Li Zhang; Michael D Abràmoff; Milan Sonka; Amde Selassie Shifera; Christine N Kay
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2016-03       Impact factor: 1.300

10.  Tenascin-C secreted by transdifferentiated retinal pigment epithelial cells promotes choroidal neovascularization via integrin αV.

Authors:  Yoshiyuki Kobayashi; Shigeo Yoshida; Yedi Zhou; Takahito Nakama; Keijiro Ishikawa; Yuki Kubo; Mitsuru Arima; Shintaro Nakao; Toshio Hisatomi; Yasuhiro Ikeda; Akira Matsuda; Koh-Hei Sonoda; Tatsuro Ishibashi
Journal:  Lab Invest       Date:  2016-09-26       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.